Orphanix Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
Orphanix General Information
Description
Developer of drugs designed to treat rare diseases. The company formulates drugs for diseases that are not very common among humans, enabling clinicians to solve a high unmet medical need in the pediatric orphan drug space.
Contact Information
Website
www.orphanix.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Primary Office
- Lederergasse 18/1
- Linz, 4020
- Austria
Orphanix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 15-Jun-2015 | Completed | Generating Revenue |
Orphanix Patents
Orphanix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019386241-A1 | Aqueous paediatric retinol formulations | Pending | 26-Nov-2018 | 000000000 | |
| CA-3117767-A1 | Aqueous paediatric retinol formulations | Pending | 26-Nov-2018 | 000000000 | |
| EP-3880168-A1 | Aqueous paediatric retinol formulations | Pending | 26-Nov-2018 | 000000000 | |
| US-20220000802-A1 | Aqueous paediatric retinol formulations | Pending | 26-Nov-2018 | A61K9/1075 |
Orphanix Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Philipp Novak | Co-Founder, Chief Executive Officer & Managing Director | ||
| Stefan Johansson Ph.D | Co-Founder & Chief Medical Officer |